(October 9, 2008)--About 25 percent of the teenage girls in the U.S. have been vaccinated against the virus that causes most cervical cancers, the federal government says.
The vaccine Gardasil is a three-shot series that targets the strain of a virus that causes 70 percent of cervical cancers.
Health officials recommend that girls get the shots when they are 11 or 12, before they become sexually active.
Proponents of the vaccine hoped for much higher vaccination rates.
They say the shots could dramatically reduce the nearly 4,000 cervical cancer deaths in the country each year.
But experts say many families are cautious about the safety of new vaccines.
The vaccine is expensive, and questions remain about whether it provides lifetime immunity or if a booster shot will be needed.
Merck, the company that makes Gardasil, says it's pleased with the vaccination rate.
Save
Email
Print
0 comments
